期刊文献+

同型半胱氨酸抑制人脐静脉内皮细胞eNOS活性 被引量:3

Homocysteine inhibits activity of eNOS in endothelial cells from human umbilical vein
下载PDF
导出
摘要 目的研究不同浓度同型半胱氨酸(Hcy)作用不同的时间对人脐静脉内皮细胞中内皮型一氧化氮合酶(eNOS)活性的影响机制。方法取2~3代人脐静脉内皮细胞(HUVECs)与不同浓度Hcy孵育以及孵育不同时间。用Western blot和实时荧光定量RT-PCR法检测热休克蛋白90(HSP90)、蛋白激酶B(Akt)蛋白表达,小凹蛋白(Caveolin-1)、eNOS、P-eNOS蛋白及mRNA的表达,二甲基精氨酸二甲胺水解酶(DDAH)mRNA表达。结果与静息和激活状态下的对照组相比,在Hcy作用下,Caveolin-1蛋白的表达上调(P<0.05),而Akt蛋白的表达下调(P<0.05),且均呈浓度、时间依赖性。eNOS蛋白的表达无明显改变。Hcy对其他检测指标无影响。结论 Hcy引起的eNOS活性降低与增强Caveolin-1蛋白表达使其与eNOS藕联增加,减少HSP90、Akt和eNOS复合物的形成,进而抑制了eNOS的活性有关。 Objective To study the mechanism of homocysteine(Hcy) on eNOS activity in human umbilical vein endothelial cells(HUVECs).Methods HUVECs were collected and cultured.Then the second passage of HUVECs were cultured with different Hcy concentrations for different times.The expression of HSP90,Akt,caveolin-1,eNOS,P-eNOS proteins were detected by Western blot and the expression of Caveolin-1,eNOS,DDAH mRNA by RT-PCR.Results Compared with control group,both in base and calcium ionophore activated state,the expression of Caveolin-1 group increased obviously(P0.05) in concentration and time-dependent manner,but the expression of Akt showed decreasing(P0.05).The expression of eNOS did not change significantly.There was no difference in the expression of HSP90,eNOS,P-eNOS protein and mRNA among every group.DDAH mRNA among every group too.Conclusions There was no relationship between decreasing activity of eNOS induced by Hcy and eNOS expression,Hcy probably can increase the association of Caveolin-1 and eNOS by enhancing the expression of Caveolin-1,and reduce the complex formation of Caveolin-1,Akt,Caveolin-1 in HUVEC both in base and activated state,which can decrease the activity of eNOS.
出处 《基础医学与临床》 CSCD 北大核心 2011年第8期864-868,共5页 Basic and Clinical Medicine
基金 国家自然科学基金(30860099)
关键词 同型半胱氨酸 ENOS 人脐静脉内皮细胞 A23187 homocyeteine eNOS human umbilical vein endothelial cell A23187
  • 相关文献

参考文献2

二级参考文献16

  • 1阮骊韬,曹铁生,段云友,庄磊,扬一林.不同浓度Hcy对培养的人脐静脉内皮细胞NO及eNOS转录水平的影响[J].第四军医大学学报,2003,24(18):1697-1699. 被引量:7
  • 2张瑞芬,凌文华,马静,陈铁峰.慢性轻度高同型半胱氨酸血症对大鼠NO影响[J].中国公共卫生,2005,21(12):1466-1467. 被引量:5
  • 3张会敏,何芳,邓峰美,钟华,徐芬,张海洋.人脐静脉内皮细胞原代培养方法的建立[J].石河子大学学报(自然科学版),2006,24(5):572-575. 被引量:3
  • 4Graham I M,Daly L,Refsum H,et al.Plasma homocysteine as a risk factor for vascular disease.The European Concerted Action Project[J].JAMA,1997,277(22):1775-1781.
  • 5Stanger O,Herrmann W,Pietrzik K,et al.DACH-LIGA homocystein (german,austrian and swiss homocysteine society):consensus paper on the rational clinical use of homocysteine,folic acid and B-vitamins in cardiovascular and thrombotic diseases:guidelines and recommendations[J].Clin Chem Lab Med,2003,41 (11):1392-1403.
  • 6Fischer P A,Dominguez G N,Cuniberti L A,et al.Hyperhomocysteinemia induces renal hemodynamic dysfunction:is nitric oxide involved?[J]J Am Soc Nephrol 2003;14(2):653-660.
  • 7Romerio S C,Linder L,Nyfeler J,et al.Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults[J].Atherosclerosis,2004,176(2):337-344.
  • 8Jin L,Abou Mohamed G,Caldwell R B,et al.Endothelial cell dysfunction in a model of oxidative stress[J].Med Sci Monit,2001,7(4):585-591.
  • 9Xiaohui Zhang,Hong Li,Haoli Jin,et al.Effects of homocysteine on endothelial nitric oxide production[J].Am J physiol Renal physiol,2000,279(4):671-678.
  • 10Dhillon B,Badiwala M V,Maitland A,et al.Tetrahydrobiopterin attenuates homocysteine induced endothelial dysfunction[J].Mol Cell Biochem,2003,247(12):223-227.

共引文献30

同被引文献23

  • 1王朝晖,杜林林,龚平,罗丰,刘小楣.动脉粥样硬化形成过程中血小板活化和同型半胱氨酸动态变化及其相关性研究[J].中国血液流变学杂志,2006,16(1):12-14. 被引量:6
  • 2Yi-ming PAN Yong-zhong YAO Zhang-hua ZHU Xi-tai SUN Yu-dong QIU Yi-tao DING.Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells[J].Acta Pharmacologica Sinica,2006,27(12):1567-1574. 被引量:3
  • 3Howard VJ,Sides EG.Changes in plasma homocysteine in the acute phase after stroke[J].Stroke,2002,33(2):473-478.
  • 4Lawrence de Koning AB,Werstuck GH,Zhou J,et al.Hyperhomocysteinemia and its role in the development of atherosclerosis[J].Clin Biochem,2003,36(6):431-441.
  • 5Akubowski H.Molecular basis of homocysteine toxicity in humans[J].Cell Mol Life Sci,2004,61(4):470-487.
  • 6Brahmajee K.Nallamothu A,Fendrick M,et al.Homocysteine and coronary heart disease[J].Pharmacoeconomics,2002,20(7):429-442.
  • 7Fallon UB,Virtamo J,Young I,et al.Homocysteine and cerebral infarct ion in Finnish male smokers[J].Stroke,2003,34(6):1359-1363.
  • 8Towfighi A,Markovic D,Ovbiagele B.Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals:a nationwide study[J].J Neurol Sci,2010,298(1-2):153-157.
  • 9Kalita J,Kumar G,Bansal V,et al.Relationship of homocysteine with other risk factors and outcome of ischemic stroke1[J].Clin Neurol Neurosurg,2009,l11(4):364-367.
  • 10North American Symptomatic Carotid Endartetectomy Trail(NASCET)Steening Committee.North American Symptomatic Carotid Endartetectomy Trail-methods,patient characteristics and progress[J].Stroke,1991(22):711.

引证文献3

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部